tetraiodothyroacetic acid has been researched along with Breast Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, Y; Hu, F; Huang, X; Liu, X; Meng, T; Tan, Y; Yang, X; Yuan, H; Zhao, Y; Zhu, Y | 1 |
| Bharali, DJ; Davis, PJ; Mousa, SA; Yalcin, M | 1 |
| Bharali, DJ; Darwish, NH; Davis, PJ; Debreli Coskun, M; Keating, KA; Lin, HY; Mousa, SA; Sudha, T; Yalcin, M | 1 |
| Davis, FB; Davis, PJ; Glinskii, AB; Glinsky, GV; Hercbergs, AH; Lin, HY; Luidens, MK; Mousa, SA; Sun, M; Tang, HY | 1 |
| Brown, D; Davis, FB; Davis, PJ; Drusano, GL; Kulawy, R; Landersdorfer, CB; Lim, CU; Lin, C; Lin, HY; Lin, S; London, D; Louie, A; Meng, R; Mousa, SA; Queimado, L; Tang, HY; Van Scoy, B | 1 |
| Davis, FB; Davis, PJ; Lin, HY; Tang, HY; Zhang, S | 1 |
6 other study(ies) available for tetraiodothyroacetic acid and Breast Neoplasms
| Article | Year |
|---|---|
Simultaneous targeting therapy for lung metastasis and breast tumor by blocking the NF-κB signaling pathway using Celastrol-loaded micelles.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Integrin alphaVbeta3; Lung Neoplasms; Mice; Mice, Inbred BALB C; Micelles; Neoplasm Metastasis; NF-kappa B; Pentacyclic Triterpenes; Signal Transduction; Thyroxine; Triterpenes | 2018 |
Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer.
Topics: Animals; Antineoplastic Agents; Breast; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Lactic Acid; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neovascularization, Pathologic; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Thyroxine | 2013 |
Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Delivery Systems; Dynamic Light Scattering; Female; Humans; Lactic Acid; Mice, Nude; Nanoparticles; Paclitaxel; Pancreatic Neoplasms; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Thyroxine; Xenograft Model Antitumor Assays | 2017 |
Modification of survival pathway gene expression in human breast cancer cells by tetraiodothyroacetic acid (tetrac).
Topics: Breast Neoplasms; Carrier Proteins; Caspase 2; Cell Line, Tumor; Cell Proliferation; Cysteine Endopeptidases; Fibroblast Growth Factors; Gene Expression Regulation, Neoplastic; Genes, ras; Humans; Myeloid Cell Leukemia Sequence 1 Protein; Nanoparticles; Nuclear Proteins; Oligonucleotide Array Sequence Analysis; Proto-Oncogene Proteins c-bcl-2; Thrombospondin 1; Thyroxine; Vascular Endothelial Growth Factor A; X-Linked Inhibitor of Apoptosis Protein | 2009 |
Pharmacodynamic modeling of anti-cancer activity of tetraiodothyroacetic acid in a perfused cell culture system.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cetuximab; Colonic Neoplasms; Computational Biology; Drug Therapy, Combination; Female; Humans; Models, Biological; Monte Carlo Method; Nanoparticles; Resveratrol; Stilbenes; Thyroxine | 2011 |
Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor.
Topics: Breast Neoplasms; Cell Division; Cell Line, Tumor; Cell Nucleus; Enzyme Inhibitors; Estradiol; Estrogen Receptor alpha; Flavonoids; Humans; MAP Kinase Signaling System; Phosphorylation; Receptors, Estrogen; Serine; Thyroxine | 2004 |